These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33631914)

  • 1. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
    Avcı R; Mavi Yıldız A; Çınar E; Yılmaz S; Küçükerdönmez C; Akalp FD; Avcı E
    Turk J Ophthalmol; 2021 Feb; 51(1):38-44. PubMed ID: 33631914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH; Tsang CW; Mohamed S; Lee GKY; Lok JKH; Hui VWK; Tsang KK; Chen LJ; Brelen M; Lai TYY
    Ophthalmologica; 2024; 247(2):118-132. PubMed ID: 38408445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H; Bardak Y; Erçalık Y; Erdem B; Arslan G; Timlioglu S
    Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P; Tsiropoulos GN; Koronis S; Vakalis A; Asteriadis S; Stavrakas P
    Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F; Roider J; Hillenkamp J
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
    Barayev E; Tiosano A; Zlatkin R; Elul R; Dotan A; Hadayer A; Gal-Or O; Ehrlich R
    Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM; Sherman MP; Barr CC; Schaal S
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy.
    Matsunaga DR; Su D; Sioufi K; Obeid A; Wibbelsman T; Ho AC; Regillo CD
    Ophthalmol Retina; 2021 Apr; 5(4):342-347. PubMed ID: 32763426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
    Nawrocka ZA; Nawrocki J
    Ophthalmologica; 2024; 247(1):58-64. PubMed ID: 38113868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.
    Patikulsila D; Winaikosol P; Choovuthayakorn J; Watanachai N; Chaikitmongkol V; Kunavisarut P
    BMC Ophthalmol; 2022 Oct; 22(1):411. PubMed ID: 36303103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent.
    de Silva SR; Bindra MS
    Eye (Lond); 2016 Jul; 30(7):952-7. PubMed ID: 27080482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
    Jackson TL; Bunce C; Desai R; Hillenkamp J; Lee CN; Lois N; Peto T; Reeves BC; Steel DH; Edwards RT; van Meurs JC; Wafa H; Wang Y
    Trials; 2022 Jan; 23(1):99. PubMed ID: 35101110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
    Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration.
    Gabrielle PH; Delyfer MN; Glacet-Bernard A; Conart JB; Uzzan J; Kodjikian L; Arndt C; Tadayoni R; Soudry-Faure A; Creuzot Garcher CP
    Ophthalmology; 2023 Sep; 130(9):947-957. PubMed ID: 37088447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E; Steel DH; Liazos E; McHugh D; Jackson TL
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature.
    Stanescu-Segall D; Balta F; Jackson TL
    Surv Ophthalmol; 2016; 61(1):18-32. PubMed ID: 26212151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.